Vanderbilt-Ingram Cancer Institute

Nashville, Tennessee 37232

1 studies enrolling now · 1 studies all time

What they study most

HER2-low Hormone Receptor Positive Breast Cancer, Melanoma (Skin Cancer)

Studies at this site

• Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors — Recruiting now